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Abstract  
 
Background 
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease characterized by 
recurrent inflamed nodules.  No pathognomonic test is available for HS, hence the diagnosis 
is based on three clinical criteria. We used a questionnaire previously developed for 
diagnosis of HS to estimate the cross-sectional prevalence and characterize HS patients in 
the Danish Blood Donor Study cohort. 
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Method 
A questionnaire containing the HS screening questions, the Major Depression Inventory, the 
Short Form-12, as well as questions about height, weight and drinking habits was answered 
by 27,725 blood donors.  
 
Results 
The prevalence of HS was 1.8% (confidence interval 95%: 1.6% – 2.0%) in the cohort of 
Danish blood donors. Donors with HS were on average 4.7 years younger (P<0.001), had 2.7 
kg/m2 higher mean BMI (P<0.001) and were significantly more likely to smoke (OR 1.44, 
17.9 % vs 12.1 %, P=0.002) compared with donors without HS. Furthermore, significantly 
more donors with HS were classified as having a moderate depression (3.2 % vs 0.7 %, 
P<0.001). Also significantly more with HS were apprenticeship educated, received 
educational support and sickness or cash benefits.   
 
Conclusion 
The prevalence of HS in the cohort of blood donors was estimated to 1.8% (Confidence 
interval 95%: 1.6% - 2.0%).  Donors with HS reported characteristics similar to those 
reported for hospital-based HS patients such as higher BMI, smoking rates and lower 
socioeconomic status than donors without HS.  
 
Background 
Hidradenitis suppurativa (HS) is a chronic inflammatory disease of the skin. Patients suffer 
from recurrent inflamed nodules that can progress to abscesses causing scaring and the 
formation of intracutaneous tunnels. [1]  Patients with hidradenitis generally have high BMI 
[2-5] and report smoking more often than the general population. [6, 7, 2] The male to 
female ratio is approximately 1 to 3. [1]  HS is an impactful skin disease associated with 
psychological comorbidities, [8, 9] such as depression, anxiety [10, 11], low quality of life [12-
16], decreased utility [17], fatigue [18] and suicide [19]. In addition, HS patients have been 
shown to have a lower socioeconomic status [20] and a higher rate of unemployment than 
the background population. [21]  
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In spite of its clinical presentation and its clear definition HS can be difficult to diagnose. 
Globally, patients experience an average diagnostic delay of 7.2 years. [22] This can partly be 
attributed to a lack of recognition of the disease, but also to the relatively mild symptoms 
experienced by a part of the HS population. While most research is focused on the patients 
suffering from moderate to severe HS, the silent majority of mildly afflicted patients should 
not be neglected, as mild disease may progress to more severe forms over time in 
approximately 30% of cases. [23] 
In Denmark, blood donation is unremunerated and mainly motivated by altruism. Since 
2010, Danish blood donors are approached to participate in the nationwide Danish Blood 
Donor Study (DBDS). Participants are presented with a questionnaire and agree to have 
their data collected in the various Danish registers made available to researchers; allowing 
for subsequent cross-platform linkage of questionnaire and register data. Since 2015 the 
DBDS questionnaire contains diagnostic questions for HS, along with the Major Depression 
Inventory (MDI) and the Short Form-12 (SF-12) life quality questionnaires.  
The aim of this study was to estimate the prevalence of HS in a cohort of blood donors and to 
characterise donors classified as HS patients according to the screening questionnaire 
compared with blood donors who do not suffer from HS. Additionally, we compared the MDI 
scores, SF-12 scores and socioeconomic status of the two groups. 
Method 
A total of 27,765 blood donors completed the DBDS questionnaire, including HS screening 
questions and items on height, weight, drinking habits, the MDI and SF-12 along with 
questions of other phenotypes such as attention deficit hyper active disorder, migraine and 
restless legs syndrome. Questionnaire data were combined with registry data on salary, total 
income and socioeconomic status based on employment available from Statistics Denmark.  
No pathognomonic test is available for HS. The diagnosis of the disease is based on three 
criteria decided on the Hidradenitis Suppurativa Foundation’s meeting in San Francisco 
2009: (i) typical lesions, i.e. deep-seated painful nodules – ‘blind boils’ in early lesions, and 
abscesses, draining sinus, bridged scars and ‘tombstone’ double-ended pseudo-comedones in 
secondary lesions; (ii) typical topography, i.e. axillae, groins, perineal region, buttocks, and 
infra- and intermammary folds; (iii) chronicity and recurrences. [24]  
Based on these criteria a questionnaire has been developed for diagnosis of HS, using two 
simple questions. E.g. “Have you had outbreak of boils during the last 6 months?” and 
“Where and how many boils have you had?” listing the locations axilla, groin, genitals, under 
the breast and other location. We defined HS  as an affirmative answer to question 1, 
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combined with more than two boils in total for question 2,s suggested by Vinding et al. [24] 
A sensitivity of 90%  (95% Confidence interval (CI): 73–98%), a specificity of 97% (95% CI: 
85–100%), a positive predictive value of 96% and an negative predictive value of 92% were 
achieved. [24] 
The screening questionnaire was included in the Danish Blood Donor Study and used to 
identify cases of HS. Donors fulfilling the definition are referred to as “blood donors with 
HS” and other donors are referred to as “blood donors without HS”. 
 
The MDI is a validated Danish questionnaire that covers the depressive symptoms of both 
ICD-10 and DSM-IV defined depression. [25] The questionnaire covers 10 items across 12 
questions. The donors were asked how often during the past two weeks they have 
experienced depressive symptoms, e.g. “Have you felt low in spirits or sad?” For each item 
answers were given on a numeric rating scale ranging from 0 to 5 points, with more points 
indicating more depressive symptoms. Two of the items were divided into two questions 
where the highest score was used. The MDI’s ability to categorize patients as having “No 
depression” (0-20 points), “Mild depression” (21-25 points), “Moderate depression” (26-30 
points) and “Severe Depression” (31-50 points) has been validated. [26, 25]   
Short Form - 12 is a shorter version of the Short Form – 36 (SF-36), and is designed to 
provide a single-page health related quality of life survey. [27] The SF-12 provides a physical 
component summery (PCS) and a mental component summary (MCS). These scores explain 
more than 80 % of the variance in the original eight SF-36 scores. [28] To calculate the SF-12 
score, questionnaire items are weighted with different endorsements and added to a constant 
(57.65693 for PCS and 60.58847 for MCS) [29], higher scores indicating better health 
related quality of life. 
Data on income were acquired from Statistics Denmark. These data included information on 
yearly salary and yearly total income comprising salary and other income, interests and 
investments included. Furthermore, each adult in Denmark are assigned a nominal social 
economic status  based on employment. The seven most common categories can be rank 
ordered. This information was also provided by Statistics Denmark.  
The National Patient register was searched to see how many of the DBDS participants had 
the ICD-10 HS diagnosis (L73.2) in the time period 1995-2015. 
Categorical data are reported as frequency distribution and percentages.  Comparisons are 
made with Chi-squared tests or Fishers’ Exact test as appropriate.  
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For continuous data means and standard deviation or medians and interquartile range were 
used depending on normality assessed by histograms. Differences between groups were 
calculated with t-tests or Mann-Whitney U tests, likewise, depending on normality.  
To isolate the association of HS on outcomes, a multiple linear regression analyses were 
performed for continuous outcomes for the study base of blood donors adjusting for age, sex, 
BMI, smoking and HS-status. Linearity were tested with scatterplots, multivariate normality 
was tested with histograms and QQ-plots, multicollinearity was tested with correlation 
matrix with correlation coefficients less than 0.80 considered acceptable. Homoscedasticity 
was tested with residuals against predicted values.  
 
A multinomial logistic regression analysis was performed to assess the association between 
HS-status and socioeconomic rank adjusting for age, sex, BMI and smoking. For continuous 
variables outliers were assessed by converting to z-scores, removing values below -3.29 and 
over 3.29 (n=1). Multicolinearity was assessed by correlation matrix. 
Statistics was performed in SPSS 24.0 (IBM, USA, New York), a p-value less than 0.05 was 
considered statistically significant. Benjamini-Hochberg procedure for multiple testing was 
used with a false discovery rate set to 0.05. 
 
Results 
Prevalence 
A total of 27,765 blood donors completed the questionnaire, and 500 of these fulfilled the 
definition of HS, suggesting a point prevalence of 1.80% (95% CI: 1.64% – 1.96%). 
Gender and lifestyle characteristics 
We found no difference in gender distribution between the groups. In the HS group 49.8% 
were female compared with 45.7% in the non-HS group (P = 0.066). The blood donors with 
HS were younger than blood donors without HS with a mean age of 36.6 compared with 41.3 
years (P < 0.001) and they also reported a higher mean BMI of 27.0 compared with 25.7 of 
the control group (P < 0.001). Blood donors with HS were more likely to be smokers than the 
blood donors without HS group, odds ratio (OR) 1.44 (95% CI: 1.14 – 1.82). Stratified 
analysis showed that this was due to an excess of female smokers with an OR of 1.83 (95% 
CI: 1.36 – 2.48) compared with an OR of 1.05 (CI 95%: 0.73 – 1.52) for the males. There was 
no difference in self-reported frequency of beer consumption (P = 0.99), but blood donors 
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with HS drank wine significantly less frequent than blood donors without HS (P = 0.02) but 
spirits/liqueur significantly more frequent (P<0.001) (Table 1)  
Only 11 (2.2 %) of the blood donors with HS were registered with the diagnosis of HS in the 
national patient register, while 42 (0.15 %) of the blood donors without HS were registered 
with HS (P <0.001).  
Psychological co-morbidities and quality of life 
According to the MDI questions, the odds ratio of having no depression was 0.467 (95% CI: 
0.315–0.694), the odds of mild depression 1.317 (95%CI: 0.676–2.568), the odds of 
moderate depression 4.774 (95 % CI: 2.842–8.012), and the odds of severe depression 0.741 
(95%CI: 0.183–2.998) when comparing blood donors with HS to blood donors without HS.  
Both groups reported a median of 4 MDI (P = 0.615). Blood donors with HS reported more 
often a feeling of guilt or bad conscience, being subdued or slowed down and having reduced 
appetite based on ranked data (P = 0.044, P = 0.040, and P = 0.010, respectively, however, 
these were not significant after Benjamini Hochberg correction for multiple testing). No 
difference was seen for the other items. The distribution of answers to the MDI are given in 
supplementary table 1. Multivariable linear regression analysis adjusted for sex, age, BMI 
and smoking showed that concomitant HS increased MDI by an average of 1.427 (P < 0.001) 
Table 2. 
There was no significant difference between the groups in the number reporting being 
diagnosed with depression by a doctor, 51 (10.2 %) blood donors with HS, compared with 
2,094 (7.8 %) of the control group (P = 0.140). However, of those diagnosed with depression, 
blood donors with HS were significantly more often medically treated (32/51, 62.7 %) 
compared with blood donors without HS (1033/2094, 49.5 %) (P = 0.014) (Table 2).  
In the SF-12 questionnaire, blood donors with HS reported a similar median physical 
component summary of 56.5612 compared with a median of 56.5808 for the blood donors 
without HS (P = 0.619).. However, blood donors with HS reported a lower mental 
component summary with a median of 54.96 compared with 55.51 of the blood donors 
without HS (P = 0.041). See table 2. In the unadjusted analysis, blood donors with HS rated 
their general health as worse (P = 0.025), indicated that they were more limited in moderate 
activities (P = 0.019) as well as in climbing several flights of stairs (P = 0.0313). Blood 
donors with HS felt less calm and peaceful (P = 0.049), and had less energy (P = 0.008) than 
blood donors without HS. However none of these differences were significant after 
correction for multiple testing. There was no difference for the other items. The full record 
and distribution of answers to the SF-12 as well as the endorsements for each item are 
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provided in supplementary table 2. Multivariable linear regression revealed that, after 
adjusting for sex, age, BMI and smoking, HS affected neither PCS nor MCS significantly (P = 
0.262 and P = 0.067, respectively) (Table 2 and supplementary table 3). 
Income  
Blood donors with HS had a lower annual salary of 292,959 DKK compared with 331,850 
DKK of the blood donors without HS (P < 0.001). The mean total income was 337,286 DKK 
for blood donors with HS compared with 383,320.24 DKK of the group without HS (P > 
0.001). The mean difference of 38,890 DKK equals approximately 5,200 Euro (Table 2). 
After adjusting for age, sex, HS did not affect salary or total income in a linear regression 
model (P = 0.968 and 0.596, respectively) (table 2 and supplementary table 3). 
Socioeconomic ranking 
Significantly more blood donors with HS were apprenticeship educated (P <0.001), or 
received cash benefits (P <0.001).Socioeconomic status was rank ordered where applicable.  
The order of the ranking was: (1) Chief executive, (2) high skill level employee, (3) moderate 
skill level employee, (4)  basic skill level employee, (5) apprenticeship educated, (6) 
unemployed for at least 6 months in a year and (7) publicly supported (cash benefits, 
sickness benefits). This accounted for 84.3% of the persons included (85.8% of HS donors 
and 84.3% of non-HS donors). The categories “others”, “other employees”, “co-working 
spouse”, “retired” and “self-employed” were all excluded as these were a minority of cases 
and did not fit into a rank system. As a group, blood donors with HS (n = 429) had a lower 
socioeconomic rank than blood donors without HS (n = 22,587) (P < 0.001), see table 3. 
Multinomial regression showed that after adjusting for sex, BMI and age, HS negatively 
affected socioeconomic rank. Calculating odds of belonging to various socioeconomic strata 
(1-7) relative to stratum (4) the odds ratios between donors with HS and donors without HS 
were:  (1) Received sickness benefit or educational support 2.441 (95% CI: 1.107 – 5.380),  
(2) Unemployed 1.771 (95% CI -0.886 – 3.543), (3) apprenticeship educated 1.484 (95% CI: 
1.043 – 2.113), (5) employee moderate skill level 1.136 (95% CI: 0.862 – 1.497), (6) employee 
high skill level  1.097 (95 % CI: 0.816–1.474), (7) chief executive 1.464 (95 % CI: 0.859–
2.496)(Supplementary table 4).  
 
Discussion 
A prevalence of HS of 1.8% (95% CI: 1.6% - 2.0%) was found in the cohort of blood donors. 
Population based self-reported estimates of HS prevalence range between 0.97 and 2.1. [30, 
24, 31, 32] A previous study also performed as a cross-sectional study of a Danish population 
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with the same validated diagnostic questionnaire found 344 cases of HS among  16,404  
participants (prevalence 2.10%, 95% CI: 1.88 – 2.32) in the age group 30-89 years. [24] 
Blood donors in Denmark must be between 17 and 60 years old, generally healthy and weigh 
at least 50 kg. The “generally healthy” criterion will presumably preclude a certain part of the 
HS afflicted in the general population, especially those that are moderately to severely 
affected, from volunteering and being accepted as a blood donor. It has previously been 
suggested that blood donors as a group are healthier than non-donors (even before 
considering any potentially beneficial effect of blood donation). [33] Due to this selection 
bias the true prevalence in the general population may be even higher.  
The gender and lifestyle characteristics of HS patients were similar to the findings of the 
previously performed background population study (21). Blood donors with HS had higher 
BMIs and a higher rate of female smokers than blood donors without HS despite being 
younger. The significance of this is evident when considering that studies have shown that 
BMI increases with age. [34] 
In the previous Danish population study using the same diagnostic questions the mean BMI 
of HS patients was 28.6 [24] compared with 27.0 in this study. Similarly, the prevalence of 
smoking for HS patients in the general Danish population was found to be 41.2 % [24], with 
40.3%-89% [30, 35] found in French and German studies, respectively, while we found a 
smoking prevalence of 17.9 %. The fact that smoking prevalence and BMI for donors with HS 
are higher than for the  donors without HS, but lower than for HS patients in the general 
population suggest that blood donors with HS are healthier than HS cases from the general 
population, which is consistent with the known selection criteria for individuals eligible for 
donation [33].   
Several studies have shown that HS patients are prone to depressive symptoms and 
depression. [8, 11, 10, 19] In this study significantly fewer donors with HS were classified in 
the “No depression group” and more in the “Moderate depression group” according to the 
MDI scores, suggesting that HS blood donors are more depressed than non-HS donors. 
Furthermore, of blood donors reporting a clinical diagnosis of depression, significantly more 
donors with HS reported having received medical treatment for their depression, which 
suggests a propensity for more severe depression in donors with HS. Finally, the regression 
analysis of the role of HS as a predictor of MDI scores found blood donors with HS scored an 
average of 1.427 higher on the MDI (P <0.001) after adjusting for BMI, sex, age and 
smoking.  [36] 
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Socioeconomic status for blood donors with HS was significantly lower than donors without 
HS based on job description. Multinomial regression models also showed that HS negatively 
affected socioeconomic rank after adjusting for age, sex and BMI. A Dutch study found that 
hospital-recruited HS patients had a lower mean household income [20] based on ranked 
data of neighbourhood averages, compared with age and sex matched controls. However, the 
present study found no evidence that blood donors with HS had a lower personal income 
than blood donors without HS, after adjusting for age and sex. Blood donors with HS do not 
seem to have a lower socioeconomic status than their peers which may reflect the mild 
disease of the population studied.   
Blood donors with HS reportedly drink less wine but more liquor than Blood donors without 
HS, which has also been suggested to be indicative of a lower social status. [37] Interestingly, 
no difference in the consumption of beer was found. Brewer’s yeast, a component of most 
beers, has been suggested to worsen symptoms of HS. [38]  
The study was conducted to determine the prevalence of HS in a relatively healthy 
population and to characterize the HS subpopulation in this cohort. The 7.2 year average 
diagnostic delay [22] shows that many HS patients fail to be diagnosed, which is especially 
relevant in this presumably less severely affected population. Only 2.2 % of HS patients had 
the diagnosis of HS (L73.2) in the National patient register.  This demonstrates a large 
number of undiagnosed HS patients that could benefit from a diagnosis, which provides not 
only access to guideline-based treatment, but also a certainty that their boils is part of a 
disease. Early and aggressive treatment of the disease will reduce the risk of scaring, tunnel 
formation and the need for surgery. [1] However, the low number also raises questions about 
coding issues and the validity of the screening questionnaire. An in-setting validation of the 
questionnaire is recommended for blood donors. The questionnaire had an estimated 
sensitivity of 90% and specificity of 97%, which could explain the lack of difference in gender 
distribution found in this study, but also indicates that an underestimation of the true HS 
prevalence is likely. 
The large sample size is a noticeable strength of this study. However, extrapolating results 
from a study of blood donors to the general population should generally be done with great 
caution due to the selection bias, although as demonstrated the findings corresponds well 
with current knowledge. Although the within-group analysis reported here is suggested to be 
a better approach, than comparing to other population studies [39], the selection bias limits 
the external validity of our results, as it narrows the focus to the healthier part of the HS 
population. The DBDS questionnaire presented to donors changes every few years and blood 
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donors are approached again to fill out a new questionnaire. This provides the opportunity 
for follow-up data in later studies on this unique cohort.  
 
In conclusion, even in a healthy population such as blood donors, HS appears to be a 
relatively common disease. Blood donors with HS report similar characteristics to hospital 
based HS patients such as higher BMI, higher smoking rates, and lower socioeconomic 
status than their blood donor peers. It appears that HS is more prevalent than assumed 
emphasizing the challenge of diagnosing HS patients in the early relatively mild stages. 
 
Additional information: 
 
All procedures performed in studies involving human participants were in accordance with the 
ethical standards of the institutional and/or national research committee and with the 1964 Helsinki 
declaration and its later amendments or comparable ethical standards. 
 
Informed consent was obtained from all individual participants included in the study. 
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Donor Characteristics 
Donor with HS  
n = 500 
Donors without HS  
n = 27,265 
P value 
Female, n (%) 249 (49.8) 12,238 (45.7) 0.066 
Male, n (%) 251 (50.2) 14,558 (54.3)  
    
Age, mean (S.D) 36.57 (11.32) 41.30 (12.80) <0.001‡ 
Female age, mean (S.D) 35.80 (11.04) 40.53 (13.15) <0.001 
Male age, mean (S.D) 37.33 (11.57) 41.94 (12.46) <0.001 
    
BMI mean (S.D) 27.00 (5.12) 25.70 (4.07) <0.001‡ 
Female BMI, mean (S.D) 27.24 (5.61) 25.27 (4.46) <0.001 
Male BMI, mean (S.D) 26.70 (4.60) 26.05 (3.68) 0.015 
    
Smokers, n (%) 89 (17.9) 3,511 (12.1) 0.002‡ 
Non-smokers, n (%) 409 (82.1) 23,221 (86.7)  
    
Female:    
Smokers, n (%) 56 (22.5) 1,669 (13.7) <0.001 
Non-smokers, n (%) 193 (77.5) 10,546 (86.3)  
    
Male:    
Smokers, n (%) 33 (13.3) 1,842 (12.7) 0.791 
Non-smokers, n (%) 216 (86.7) 12,675 (87.3)  
    
Drinks beer:    
Never / almost never, n (%) 155 (31.8) 8,145 (30.4) 0.99 
Few times a month, n (%) 230 (46.0) 12,264  (45.8)  
Few times a week, n (%) 102 (20.4) 5,507 (20.6)  
Daily, n (%) 13 (2.6) 641 (2.4)  
    
Drinks wine:    
Never / almost never, n (%) 159 (31.8) 6,871 (25.6) 0.02‡ 
Few times a month, n (%) 249 (49.8) 13,485 (50.3)  
Few times a week, n (%) 76 (15.2) 5,547 (20.7)  
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Daily, n (%) 15 (3.0) 744 (2.8)  
    
Drinks spirits:    
Never / almost never, n (%) 278 (55.6) 16,275 (60.7) <0.001‡ 
Few times a month, n (%) 198 (39.6) 9,396 (35.1)  
Few times a week, n (%) 19 (3.8) 715 (2.7)  
Daily, n (%) 1 (0.2) 40 (0.1)  
    
Registered with HS in the national patient register  11 (2.2) 42 (0.15) <0.001‡ 
 
Table 1: Characteristics of a cohort of Danish blood donors. HS = Hidradenitis suppurativa. 
BMI = Body mass index. N = Number. S.D. =Standard Deviation. IQR= Interquartile range. 
‡=Significant after Benjamini-Hochberg correction with false discovery rate set to 0.05. 
Subanalysis of gender for smokers, BMI and age, were not included in the correction. For 
sex-stratified alcohol consumption, see supplementary table 1. 
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Questionnaire and register data 
Donors with HS           
n = 500 
Donors without HS  
n = 27,265 
P value 
Beta value for HS in 
regression (CI 95%) 
P value for HS 
beta  
Major depression Inventory, median (IQR) 4 (6) 4(5) 0.615 1.43 (0.937 – 1.917) † <0.001 
No depression, n (%) 463 (94.5 %) 25,648 (95.7 %) <0.001   
Mild depression, n (%) 9 (1.8 %) 369 (1.4 %) 0.417   
Moderate depression, n (%) 16 (3.2 %) 185 (0.7 %) <0.001   
Severe depression, n (%) 2 (0.4 %) 145 (0.5 %) 1   
Depression diagnosed by doctor, n (%) 51 (10.2 %) 2,094 (7.8 %) 0.140   
Depression treated medically, n (%) 32 (62.7 %) 1,033 (49.5 %) 0.014   
      
SF-12 PCS, median (IQR) 56.5612 (3.19) 56.5808 (3.28) 0.619 -0.23 (-0.635 – 0.173)† 0.262 
SF-12 MCS, median (IQR) 54.9672 (6.92) 55.5088 (6.49) 0.041 -0.62 (-1.256 – 0.043) † 0.067 
      
Salary, mean (S.D) 
292,959.33 
(226,324.75) 
331,849.70 
(226,983.73) 
<0.001 -365 (-179,040 – 17,209)† 0.968 
Total Income, mean (S.D) 
337,286.35 
(233,237.70) 
383,320.42 
(257,551.59) 
<0.001 -5,707 (- 26,799 – 15,384)† 0.596 
 
Table 2. Questionnaire and register data. HS = Hidradenitis suppurativa. n = Number. IQR = 
Interquartile range. S.D = Standard Deviation. SF-12 = Short form – 12. PCS= Physical component 
score, MCS = Mental component score. Beta-values for HS are given with confidence interval. † = 
Adjusted for sex, age, BMI and smoking. 
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Rank 
 Socio-economic status 
Donors with 
HS 
Donors 
without HS 
P value 
1 Chief executive, n (%) 16 (3.2 %) 858 (3.2 %) 0.998 
2 High skill level employee, n (%) 77 (15.4 %) 4,898 (18.3 %) 0.099 
3 Moderate skill level employee, n (%) 97 (19.4 %) 5,500 (20.5 %) 0.537 
4 Basic skill level employee, n (%) 115 (23 %) 7,030 (26.2 %) 0.103 
5 Apprenticeship educated, n (%) 108 (21.6 %) 3,874 (14.5 %) <0.001‡ 
6 Unemployed, at least 6 months a year, n (%) 9 (1.8 %) 282 (1.1 %) 0.118 
7 Receiver of sickness benefits, educational support 
etc., n (%) 
7 (1.4 %) 145 (0.5 %) 0.011 
Not ranked Selfemployed, 10 or more employees, n (%) 0 (0 %) 7 (0 %) - 
Not ranked Selfemployed, 5 - 9 or more employees, n (%) 1 (0.2 %) 31 (0.1 %) 0.447 
Not ranked Selfemployed, 1 - 4 or more employees, n (%) 2 (0.4 %) 123 (0.5 %) 1 
Not ranked Selfemployed, No employees, n (%) 8 (1.6 %) 630 (2.4 %) 0.367 
Not ranked Co-working spouse, n (%) 0 (0 %) 18 (0.1 %) - 
Not ranked In early retirement, n (%) 2 (0.4 %) 107 (0.4 %) 1 
Not ranked Retiree, n (%) 0 (0 %) 105 (0.4 %) 0.270 
Not ranked Post-employment benefits, n (%) 1 (0.2 %) 399 (1.5 %) 0.012 
Not ranked Cash benefits, n (%) 9 (1.8 %) 140 (0.5 %) <0.001‡ 
Not ranked Other employees, n (%) 40 (8 %) 2,420 (9 %) 0.475 
Not ranked Others, n (%) 8 (1.6 %) 226 (0.8 %) 0.069 
 
Table 3. Socioeconomic status, and P values for the difference between the groups. HS = 
Hidradenitis suppurativa. ‡=Significant after Benjamini-Hochberg correction with false 
discovery rate set to 0.05.  
 
